Buprenorphine-naloxone treatment in opioid dependence and risk of liver enzyme elevation: Results from a 12-month observational study.

CONCLUSION: This study is in line with some recent studies and provides further evidence that buprenorphine-naloxone is relatively safe with respect to liver injury. (Am J Addict 2013;XX:1-7).
PMID: 25251050 [PubMed – as supplied by publisher] (Source: American Journal on Addictions)